Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $235
Raymond James analyst Jayson Bedford maintains ICU Medical (NASDAQ:ICUI) with a Outperform and lowers the price target from $265 to $235.
Earnings Scheduled For May 9, 2022
Companies Reporting Before The Bell
• Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Recap: ICU Medical Q4 Earnings
ICU Medical (NASDAQ:ICUI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $280
Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $302 to $280.
ICU Medical Pulls Amino Acid IV Products After Foreign Substances Found In Batch
ICU Medical Inc (NASDAQ: ICUI), a California-based infusion therapy company, is
10 Biggest Price Target Changes For Thursday
Telsey Advisory Group lifted the price target on Lululemon Athletica Inc. (NASDAQ: LULU) from $460 to $485. Lululemon shares surged 13.9% to $433.58 in pre-market trading.